Krsnaa Diagnostics Share Price
Sector: Healthcare Facilities
643.05 +9.15 (1.44%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
634.00
Today’s High
651.40
52 Week Low
527.55
52 Week High
1041.80
641.20 +7.10 (1.12%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
632.05
Today’s High
652.80
52 Week Low
528.05
52 Week High
1044.00
Key Metrics
- Market Cap (In Cr) 2076.39
- Beta 0.19
- Div. Yield (%) 0.43
- P/B 2.32
- TTM P/E 32.79
- Peg Ratio 27.66
- Sector P/E 22.82
- D/E 0
- Open Price 634
- Prev Close 633.9
Krsnaa Diagnostics Analysis
Price Analysis
-
1 Week-7.25%
-
3 Months-10.55%
-
6 Month-32.15%
-
YTD-28.39%
-
1 Year5.82%
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 3
- Buy
- 1
- 1
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 3
- 3
- 2
- 3
Krsnaa Diagnostics News
Hospital stocks rise as govt plans daycare cancer centers in district hospitals
2 min read . 01 Feb 2025Ujjivan SFB, Data Patterns, among 55 companies to post Q4 results today
1 min read . 18 May 2024Krsnaa Diagnostics share price slumps over 10% as Rajasthan NHM cancels contract
1 min read . 20 Jul 2023Krsnaa Diagnostics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 717.16
- Selling/ General/ Admin Expenses Total
- 136.78
- Depreciation/ Amortization
- 88.32
- Other Operating Expenses Total
- 220.99
- Total Operating Expense
- 615.36
- Operating Income
- 101.8
- Net Income Before Taxes
- 102.69
- Net Income
- 77.61
- Diluted Normalized EPS
- 23.56
- Period
- 2025
- Total Assets
- 1281.6
- Total Liabilities
- 398.83
- Total Equity
- 882.77
- Tangible Book Valueper Share Common Eq
- 272.47
- Period
- 2025
- Cashfrom Operating Activities
- 87.33
- Cashfrom Investing Activities
- -99.61
- Cashfrom Financing Activities
- 13.75
- Net Changein Cash
- 1.47
- Period
- 2024
- Total Revenue
- 619.63
- Selling/ General/ Admin Expenses Total
- 255.54
- Depreciation/ Amortization
- 74.55
- Other Operating Expenses Total
- 66.59
- Total Operating Expense
- 549.88
- Operating Income
- 69.75
- Net Income Before Taxes
- 70.01
- Net Income
- 56.84
- Diluted Normalized EPS
- 17.32
- Period
- 2024
- Total Assets
- 1171.91
- Total Liabilities
- 362.11
- Total Equity
- 809.8
- Tangible Book Valueper Share Common Eq
- 250.04
- Period
- 2024
- Cashfrom Operating Activities
- 24.35
- Cashfrom Investing Activities
- -128.88
- Cashfrom Financing Activities
- 84.19
- Net Changein Cash
- -20.35
- Period
- 2023
- Total Revenue
- 487.12
- Selling/ General/ Admin Expenses Total
- 208.72
- Depreciation/ Amortization
- 53.78
- Other Operating Expenses Total
- 81.21
- Total Operating Expense
- 417.88
- Operating Income
- 69.24
- Net Income Before Taxes
- 80.2
- Net Income
- 62.11
- Diluted Normalized EPS
- 19.25
- Period
- 2023
- Total Assets
- 909.89
- Total Liabilities
- 171.16
- Total Equity
- 738.74
- Tangible Book Valueper Share Common Eq
- 234.38
- Period
- 2023
- Cashfrom Operating Activities
- 76.3
- Cashfrom Investing Activities
- -108.89
- Cashfrom Financing Activities
- -33.14
- Net Changein Cash
- -65.73
- Period
- 2022
- Total Revenue
- 455.45
- Selling/ General/ Admin Expenses Total
- 155.44
- Depreciation/ Amortization
- 41.39
- Other Operating Expenses Total
- 107.99
- Total Operating Expense
- 365.11
- Operating Income
- 90.34
- Net Income Before Taxes
- 86.51
- Net Income
- 68.39
- Diluted Normalized EPS
- 22.95
- Period
- 2022
- Total Assets
- 876.15
- Total Liabilities
- 191.74
- Total Equity
- 684.41
- Tangible Book Valueper Share Common Eq
- 217.24
- Period
- 2022
- Cashfrom Operating Activities
- 128.42
- Cashfrom Investing Activities
- -240.64
- Cashfrom Financing Activities
- 175.99
- Net Changein Cash
- 63.78
- Period
- 2021
- Total Revenue
- 396.46
- Selling/ General/ Admin Expenses Total
- 110.19
- Depreciation/ Amortization
- 37.44
- Other Operating Expenses Total
- -144.58
- Total Operating Expense
- 86.79
- Operating Income
- 309.66
- Net Income Before Taxes
- 295.45
- Net Income
- 184.93
- Diluted Normalized EPS
- 59
- Period
- 2021
- Total Assets
- 604.53
- Total Liabilities
- 372.67
- Total Equity
- 231.87
- Tangible Book Valueper Share Common Eq
- 73.46
- Period
- 2021
- Cashfrom Operating Activities
- 102.56
- Cashfrom Investing Activities
- -61.14
- Cashfrom Financing Activities
- 30.84
- Net Changein Cash
- 72.26
- Period
- 2020
- Total Revenue
- 258.43
- Selling/ General/ Admin Expenses Total
- 92.35
- Depreciation/ Amortization
- 32.41
- Other Operating Expenses Total
- 252.56
- Total Operating Expense
- 405.05
- Operating Income
- -146.62
- Net Income Before Taxes
- -158.33
- Net Income
- -111.95
- Diluted Normalized EPS
- -35.66
- Period
- 2020
- Total Assets
- 629.98
- Total Liabilities
- 826.96
- Total Equity
- -196.98
- Tangible Book Valueper Share Common Eq
- -63.22
- Period
- 2020
- Cashfrom Operating Activities
- 37.81
- Cashfrom Investing Activities
- -76.65
- Cashfrom Financing Activities
- 5.78
- Net Changein Cash
- -33.06
- Period
- 2019
- Total Revenue
- 209.23
- Selling/ General/ Admin Expenses Total
- 71.65
- Depreciation/ Amortization
- 25.64
- Other Operating Expenses Total
- 157.84
- Total Operating Expense
- 272.47
- Operating Income
- -63.24
- Net Income Before Taxes
- -77.73
- Net Income
- -58.06
- Diluted Normalized EPS
- -18.49
- Period
- 2019
- Total Assets
- 528.99
- Total Liabilities
- 613.91
- Total Equity
- -84.92
- Tangible Book Valueper Share Common Eq
- -27.31
- Period
- 2019
- Cashfrom Operating Activities
- 58.27
- Cashfrom Investing Activities
- -199.25
- Cashfrom Financing Activities
- 124.27
- Net Changein Cash
- -16.72
- Period
- 2025-03-31
- Total Revenue
- 186.08
- Selling/ General/ Admin Expenses Total
- 32.78
- Depreciation/ Amortization
- 21.96
- Other Operating Expenses Total
- 58.77
- Total Operating Expense
- 155.05
- Operating Income
- 31.03
- Net Income Before Taxes
- 28.61
- Net Income
- 20.68
- Diluted Normalized EPS
- 6.28
- Period
- 2025-03-31
- Total Assets
- 1281.6
- Total Liabilities
- 398.83
- Total Equity
- 882.77
- Tangible Book Valueper Share Common Eq
- 272.47
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 87.33
- Cashfrom Investing Activities
- -99.61
- Cashfrom Financing Activities
- 13.75
- Net Changein Cash
- 1.47
- Period
- 2024-12-31
- Total Revenue
- 174.51
- Selling/ General/ Admin Expenses Total
- 35.86
- Depreciation/ Amortization
- 22.7
- Other Operating Expenses Total
- 53.67
- Total Operating Expense
- 152.14
- Operating Income
- 22.37
- Net Income Before Taxes
- 25.48
- Net Income
- 19.42
- Diluted Normalized EPS
- 5.88
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 186.34
- Selling/ General/ Admin Expenses Total
- 35.06
- Depreciation/ Amortization
- 22.2
- Other Operating Expenses Total
- 56.97
- Total Operating Expense
- 159.14
- Operating Income
- 27.2
- Net Income Before Taxes
- 25.4
- Net Income
- 19.6
- Diluted Normalized EPS
- 5.92
- Period
- 2024-09-30
- Total Assets
- 1294.54
- Total Liabilities
- 453.78
- Total Equity
- 840.76
- Tangible Book Valueper Share Common Eq
- 259.66
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 19.71
- Cashfrom Investing Activities
- -54.71
- Cashfrom Financing Activities
- 43.9
- Net Changein Cash
- 8.9
- Period
- 2024-06-30
- Total Revenue
- 170.23
- Selling/ General/ Admin Expenses Total
- 33.08
- Depreciation/ Amortization
- 21.47
- Other Operating Expenses Total
- 51.59
- Total Operating Expense
- 149.03
- Operating Income
- 21.2
- Net Income Before Taxes
- 23.2
- Net Income
- 17.92
- Diluted Normalized EPS
- 5.46
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 166.28
- Selling/ General/ Admin Expenses Total
- 32.46
- Depreciation/ Amortization
- 18.12
- Other Operating Expenses Total
- 47.13
- Total Operating Expense
- 140.7
- Operating Income
- 25.59
- Net Income Before Taxes
- 22.6
- Net Income
- 18.73
- Diluted Normalized EPS
- 5.55
- Period
- 2024-03-31
- Total Assets
- 1171.91
- Total Liabilities
- 362.11
- Total Equity
- 809.8
- Tangible Book Valueper Share Common Eq
- 250.04
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 24.35
- Cashfrom Investing Activities
- -128.88
- Cashfrom Financing Activities
- 84.19
- Net Changein Cash
- -20.35
- Period
- 2023-12-31
- Total Revenue
- 158.32
- Selling/ General/ Admin Expenses Total
- 29.65
- Depreciation/ Amortization
- 21.23
- Other Operating Expenses Total
- 56.92
- Total Operating Expense
- 142.16
- Operating Income
- 16.16
- Net Income Before Taxes
- 16.1
- Net Income
- 12.97
- Diluted Normalized EPS
- 3.97
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Krsnaa Diagnostics Technical
Moving Average
SMA
- 5 Day668.58
- 10 Day691.61
- 20 Day723.55
- 50 Day747.08
- 100 Day791.28
- 300 Day810.03
Krsnaa Diagnostics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Artemis Medicare Services
- 249.85
- -0.95
- -0.38
- 348.3
- 144.5
- 3456.38
- Shalby
- 201.5
- 1.8
- 0.9
- 325
- 177.25
- 2166.05
- Krsnaa Diagnostics
- 643.05
- 9.15
- 1.44
- 1041.8
- 527.55
- 2076.39
- Dr. Agarwal's Eye Hospital
- 4370
- -27.9
- -0.63
- 7300
- 2800
- 2054.22
- Gpt Healthcare
- 155
- -1.05
- -0.67
- 206.5
- 126.15
- 1280.34
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Artemis Medicare Services
- 46.48
- 4.05
- 9.91
- 5.88
- Shalby
- 25.45
- 2.14
- 6.37
- 8.2
- Krsnaa Diagnostics
- 27.59
- 2.38
- 16.02
- 16.81
- Dr. Agarwal's Eye Hospital
- 43.19
- 12.79
- 29.64
- 10.83
- Gpt Healthcare
- 26.57
- 5.94
- 21.36
- 10.33
Krsnaa Diagnostics Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results & Final Dividend
- 12-Feb-25
- Quarterly Results
- 25-Oct-24
- Quarterly Results
- 06-Aug-24
- Quarterly Results
- 18-May-24
- Audited Results & Final Dividend
- 12-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 12-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results & Final Dividend
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 13-Apr-25
- 11-Mar-25
- POM
- 21-Sept-24
- 07-Aug-24
- AGM
- 07-Apr-24
- 05-Mar-24
- POM
- 25-Sept-23
- 14-Aug-23
- AGM
- 27-Sept-22
- 04-Aug-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 12-May-25
- -
- -
- 2.75
- 21-May-24
- 13-Sept-24
- 13-Sept-24
- 2.5
- 29-May-23
- -
- 15-Sept-23
- 2.75


